Terms and Conditions

These Terms and Conditions govern your membership in the APCA drug consortium program. By enrolling, you agree to abide by these Terms and Conditions.

Enrollment

To enroll, Members, which includes self-employed individuals, company-employed individuals, and Designated Employee Representatives (DERs), must provide accurate and complete registration information and pay membership and company registration fees, if applicable. Members are responsible for maintaining and updating Member or Company information.

Payment Terms

Membership fees must be paid in full at the time of enrollment. Membership is valid for one year from the enrollment date. Membership will auto renew unless the Member withdraws from the program. If the membership lapses and the Member restarts the program, that Member may be subject to additional fees.

Membership Pausing

Memberships can be paused for any period of time. If memberships are paused for 90 or more days within any 180 day window, an additional drug test is required upon reactivation. APCA will charge a reactivation fee to cover the cost of this drug test. If memberships are paused for less than 90 days in a 180 day window, no additional test is required upon reactivation. Memberships that are paused will not be granted additional time toward their membership for the deactivation period. Members will continue to be billed on an annual basis while their account is paused.

Refunds

All payments and fees for any product or service are non-refundable. Extenuating circumstances will be considered on a case-by-case basis.

One-Time Drug Tests

APCA may offer additional or related services such as one-time drug tests. If a member purchases any of these services, the service or payment for it cannot be transferred to a consortium membership.

Compliance Obligations

Members must adhere to all program requirements, including random drug testing protocols. If Members fail to adhere to random testing protocols, they may be reported to the US Coast Guard. Members must ensure compliance with all relevant laws and regulations.

Consent for Release of Confidential Information

The Member acknowledges that he or she is self-employed or the Designated Employee Representative (DER) and is authorized to receive drug testing results performed through the APCA random drug testing program as outlined in 46 CFR and 49 CFR. The Member understands that the Medical Review Officer (MRO) is required to report non-negative drug test results to the employer and regulating agencies, i.e. the local USCG Sector Office. The Member consents for the APCA MRO to report Registrant's verified non-negative drug test results to APCA as the Consortium/Third Party Administrator (C/TPA). This period of consent shall coincide with the period of the Member's enrollment in APCA and may be withdrawn at any time upon delivery of the Member's written notice to APCA. Note: consent cannot be withdrawn to avoid reporting of non-negative drug tests as legally required under applicable CFR regulations.

Confidentiality and Data Protection

APCA will maintain the confidentiality of all Member information and records. Data will be shared only as required by law or with authorized personnel.

Amendments to Terms and Conditions

APCA reserves the right to amend these Terms and Conditions at any time.

Limitation of Liability

APCA is not responsible for any penalties, fines, or damages incurred as a result of a Member's non-compliance with regulatory requirements.

Contact Information

For any questions or concerns regarding these Terms and Conditions, please contact:

By enrolling, you acknowledge that you have read, understood, and agree to these Terms and Conditions.